Pheiron
pheiron.comUnlocking patient-centric drug discovery with artificial intelligence and population-scale genetics.
Pheiron is building the foundational tech stack for next-generation drug discovery. By combining AI with population-scale biobank data, their platform enables precise patient phenotyping, allowing biopharma to predict treatment outcomes, design smarter trials, and dramatically increase success rates.
Pheiron's vision is clear and ambitious: to become the fundamental tech stack powering drug discovery programs globally, setting a new industry standard for efficiency and success.
Key facts
In portfolio since
2025
Location
Berlin, Germany
Sector
AI-Driven Healthcare
Why it matters
Understanding which patients will benefit from a therapy is one of the most entrenched challenges in drug development. Despite advances in genomics and AI, most clinical trials still fail because we lack the tools to predict real-world patient responses. This uncertainty leads to costly trial failures, delayed treatments, and missed opportunities for patients in need.